View drug registration information details.


ItemsRegistration information
ID53
No53
Brand NameLEVOMET
IngredientsLEVODOPA 250 MG, CARBIDOPA MONOHYDRATE 27 MG EQ.TO CARBIDOPA 25 MG
Dosage FormTABLET
Primary PackagingALU-PVC/PVDC BLISTER
StorageSTORE AT TEMPERATURE NOT MORE THAN 30.C
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPRESCRIPTION ONLY
ATC ClassificationN04BA01
Pharmaceutical ClassXXX
IndicationsTREATMENT OF IDIOPATHIC PARKINSON'S DISEASE, POSTENCEPHALITIC PARKINSONISM, OR SYMPTOMATIC PARKINSONISM, WHICH MAY FOLLOW INJURY TO THE NERVOUS SYSTEM BY CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION, TO PERMIT ACHIEVEMENT OF SYMPTOMATIC RELIEF WITH A LOWER DOSAGE OF LEVODOPA THAN WITH LEVODOPA ALONE.
ContraindicationsRISK BENEFIT SHOULD BE CONSIDERED WHEN THE FOLLOWING MEDICAL PROBLEMS EXIST: BRONCHIAL ASTHMA, EMPHYSEMA, AND OTHER SEVERE PULMONARY DISEASES…
Side Effects-
Unit Price-
EDL No
DescriptionLIGHT BLUE, OVAL BICONVEX TABLET WITH SCORED ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerAI KEN PHARMA CO., LTD
ManufacturerUNISON LABORATORIES CO., LTD
CountryTHAILAND
Import Registration No2A 51/51
Import Registration Date2008-05-01
ActivityCERTIFICATE RELEASED
Applied Date2022-12-15
FDD Registration No12 I 3264/08
FDD Registration Date2023-04-19
Expiry Date2026-04-18

Back to drug list